コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al cancer specimens (27 left-sided, 33 right-sided).
2 Significance threshold was p<0.025 (one sided).
3 vs 32.0%, P = 0.043 (1-sided), P = 0.074 (2-sided)].
4 .1% vs 8.0%, P = 0.516 (1-sided), P = 1.0 (2-sided)].
5 essing group [6.1 vs 14.7 days, P = 0.019 (2-sided)].
6 Statistical tests were 2-sided.
7 All statistical tests were 2-sided.
8 t-sided (10) while only 2 of them were right-sided.
9 All statistical tests were 2-sided.
14 tes of SVR12 and relapse rates and their two-sided 90% CI (Clopper-Pearson method) were provided.
16 n-inferiority was concluded if the lower two-sided 90% CI of the seroconversion rate difference betwe
17 rapy, with an absolute difference of 7.6% (1-sided 90% CI upper limit, 13.0%) in attainment of clinic
18 ne group (difference from control 11.0%; two-sided 90% confidence limit, -11.0% to 32.9%; P=0.01 for
19 ne group (difference from control 16.4%; two-sided 90% confidence limit, -4.3% to 37.1%; P=0.002 for
20 d non-inferior if the upper limit of the one-sided 95 % confidence interval (CI) for the difference b
21 cemia was defined as an upper limit of the 2-sided 95% CI for a rate ratio of 1.10 or lower; if nonin
22 of active yaws if the lower limit of the two-sided 95% CI for the difference in rates was higher than
23 rity was shown if the upper limit of the two-sided 95% CI for the local relapse hazard ratio [HR] was
24 was concluded if the lower limit of the two-sided 95% CI for the treatment difference was greater th
27 ometric mean Ki-67 suppression of 83.8% (one-sided 95% CI, >/= 79.0%) for the combination and 66.0% (
29 f randomization (risk difference of -0.3% [1-sided 95% CI, -4% to infinity]; P < .001 for noninferior
32 ecificity (from 17% to 33%; lower bound of 1-sided 95% CI, 0.73%; prespecified 1-sided P = .04), whil
33 mean amblyopic-eye VA improved 1.05 lines (2-sided 95% CI, 0.85-1.24 lines) in the binocular group an
34 es) in the binocular group and 1.35 lines (2-sided 95% CI, 1.17-1.54 lines) in the patching group, wi
36 than during usual care (upper limit of the 1-sided 95% CI, 2.1% [within the noninferiority margin of
38 ssion-free survival at 12 weeks was 57.2% (2-sided 95% CI, 42.4%-68.8%), and the median PFS was 17.9
39 in the binocular group and by 6.5 letters (2-sided 95% CI: 4.4-8.5 letters) in the patching group.
41 was 5.4% for both devices (upper bound of 1-sided 95% confidence interval 1.8%, Pnoninferiority=0.00
42 VA improved from baseline by 3.5 letters (2-sided 95% confidence interval [CI]: 1.3-5.7 letters) in
46 in the rituximab treatment group (4.3%; one-sided 97.5% CI -4.25), which lay on the positive side of
47 s group (proportional difference of -1.2%; 1-sided 97.5% CI bound of the difference in SRE rate betwe
48 inferiority of response was shown if the one-sided 97.5% CI lay on the positive side of the -7% margi
49 phine were responders, an 8.8% difference (1-sided 97.5% CI, 0.009 to infinity; P < .001 for noninfer
52 dance was non-inferior to IVUS guidance (one-sided 97.5% lower CI -0.70 mm(2); p=0.001), but not supe
55 microfluidic channel fabricated with double-sided adhesive tape) and all the optical components are
58 even of 174 without; P < .01), or with right-sided allograft placement (10 of 64 vs seven of 131 left
61 indicate that an adequately powered (80%; 2-sided alpha = .05) open-label randomized trial using 50%
63 an rPFS hazard ratio (HR) of 0.6 with a two-sided alpha error of .05 and 80% power to detect a targe
64 rch versus control had 90% power at 2.5% one-sided alpha for hazard ratio (HR) 0.75, requiring roughl
65 ere noninferiority (margin: 5 letters at a 1-sided alpha level 0.1) in best-corrected visual acuity (
66 nt was progression-free survival using a two-sided alpha level of 0.2 and statistical power of 0.8.
67 which we assessed non-inferiority with a one-sided alpha of 0.025, and superiority with a two-sided a
70 east a 50% reduction in 3-year LRF rate (one-sided alpha, 0.10; power 90%), assuming a 35% LRF rate f
71 east a 50% reduction in 3-year LRF rate (one-sided alpha, 0.10; power, 90%), assuming a 35% LRF rate
74 study was designed with 80% power for a one-sided alternative at a 10% level of significance to dete
75 l rate (DCR) of 40% was tested against a one-sided alternative of a true DCR of 60% (alpha = beta = 0
77 follow-up screenings, 33 (78.6%) were right sided and 22 (52.4%) were flat, compared with 45.4% (P <
80 ecordings in 27 patients with TLE (67% right sided) and 27 matched controls to examine functional con
81 ical tests used in the analysis were all two-sided, and a p-value of <0.05 was considered statistical
83 ps in the intention-to-treat population (two-sided assessment), based on local evaluation of tumour s
84 loss, non-inferiority was tested using a one-sided asymptotic test, against a non-inferiority margin
86 ratio: 0.0007 +/- 0.0088, P = .604), and one-sided Bayes factors provided substantial evidence agains
87 atio: -0.0011 +/- 0.0093, P = .521), and one-sided Bayes factors provided substantial to strong evide
91 correlation coefficient, 0.205; P = .001, 2-sided), but no association was found between uveitis act
94 atients undergoing ultrasound-assisted right-sided central venous catheterization compared with 92 se
95 r a single-operator ultrasound-guided, right-sided, central venous catheter insertion verifies proper
97 fined as receiving short- or long-term right-sided circulatory support, continuous inotropic support
99 reporting data on overall survival for left-sided colon cancer (LCC) compared with right-sided colon
100 reporting data on overall survival for left-sided colon cancer (LCC) compared with right-sided colon
101 The risk was found to be highest for left-sided colon cancer (OR = 1.21; 95% CI = 1.00-1.45) and a
107 survival for right-sided compared with left-sided colon cancer: the hazard ratios were 1.00 (95% CI,
108 t colitis and spontaneous emergence of right-sided colonic tumors resulting from IL-10 deficiency.
110 rrelates with the development of human right-sided colorectal tumors with epigenetic loss of MLH1.
111 Human sessile serrated adenomas and right-sided colorectal tumors with epigenetic loss of MutL hom
112 o difference in long-term survival for right-sided compared with left-sided colon cancer: the hazard
113 versatile method, that requires only single sided contact, we measure enhanced radiative conduction
117 llocated to IMNI, whereas patients with left-sided disease were allocated to no IMNI because of the r
119 y biomarker discovery, and possibly the many-sided effects of senescence-associated secretory phenoty
122 sion at week 4 (38% vs. 13%, P=0.04 by a two-sided Fisher's exact test in the A5340 trial; and 80% vs
123 340 trial; and 80% vs. 13%, P<0.001 by a two-sided Fisher's exact test in the NIH trial) but the diff
124 0.05) and Neisseria lactamica (P < 0.002) (2-sided Fisher's exact test) was more likely in the smalle
125 threshold for significance of p<0.00825 (one-sided) for the analysis of overall survival and a thresh
126 We used penalized logistic regression and 1-sided gene-burden analyses to test for association of ra
131 ehensive physiological assessment with right-sided heart catheterization and radionuclide ventriculog
132 rdiac magnetic resonance (MR) imaging, right-sided heart catheterization, and 6-minute walk testing w
133 tery pressures at echocardiography and right-sided heart catheterization, medications, chronic lung d
134 ents with pulmonary hypertension due to left-sided heart disease or lung disease, the use of pulmonar
136 pulmonary artery pressure compared with left-sided heart disease-TR with sinus rhythm (all P<0.05).
140 validate a novel risk score for early right-sided heart failure (RHF) after left ventricular assist
141 clinical presentation of predominantly right-sided heart failure, in the absence of significant left
142 flected by increased ratio of right- to left-sided heart filling pressures (0.64+/-0.17 versus 0.56+/
144 .481, 95% CI: 1.141-6.024; P = 0.024), right-sided hepatectomy (HR: 2.143, 95% CI: 1.544-2.975; P < 0
148 ing technique, our cardiac LSFM enables dual-sided illumination to rapidly uncover the architecture o
149 sed appendices successfully, which were left-sided in a malrotated patient, retrocecal, subhepatic, r
150 she presented with a stage II (T2N1), right-sided, invasive ductal carcinoma considered grade 2 of 3
151 ssfully introduced incorporating both single-sided iontronic devices and the skin itself as the press
152 ing Tests A (P = .03) and B (P = .05), right-sided Jamar grip strength (P = .02), Rapid Pace Walk (P
153 s for both males and females despite the one-sided killing of male reproductives by larval female sol
154 Congenital heart defects involving left-sided lesions (LSLs) are relatively common birth defects
156 nalyses were carried out by flipping of left-sided lesions, so that all strokes were transformed to t
157 lateral breast cancer, 0.66; P=0.01 by a two-sided log-rank test stratified according to nodal status
161 ere classified as having left-sided or right-sided mCRC, defined, respectively, as patients whose tum
162 ere classified as having left-sided or right-sided mCRC, defined, respectively, as patients whose tum
163 r binds two molecules of Prc and forms three-sided MepS-docking cradles using its tetratricopeptide r
165 ye (VSD) imaging technique based on a double-sided microscope that can image two sides of a nervous s
169 available literature for prevalence of right-sided-only lesions vary between 20.5 and 48.1 %, with as
170 l class, longer VT cycle lengths, and a left-sided-only procedure predicted the combined endpoint of
173 teractions that have the same direction (one-sided or bidirectional hypotheses) or are proportional t
174 FIRE-3 trials were classified as having left-sided or right-sided mCRC, defined, respectively, as pat
175 FIRE-3 trials were classified as having left-sided or right-sided mCRC, defined, respectively, as pat
177 FEV1 was 7.0% (97.5% CI, 3.4% to infinity; 1-sided P < .001), and the between-group St George's Respi
182 ely, and showed significant improvement (one-sided p = .001 for both groups) compared with placebo (-
186 ar LRF rate was 23% (95% CI, 13% to 36%; one-sided P = .03) by binomial proportional estimate using t
187 und of 1-sided 95% CI, 0.73%; prespecified 1-sided P = .04), while high sensitivity (93%) was preserv
192 ar LRF rate was 42% (95% CI, 28% to 56%; one-sided P = .9) by binomial proportional estimate using th
193 ials that test a reduction of therapy, a one-sided P value </= .10 was used to indicate statistical s
196 testosterone and their controls (with a two-sided p value of 0.05 and a power of 80%) would require
198 hazard ratio of 0.63 (95% CI 0.50-0.79; one-sided p<0.0001); median survival was 10.6 months (95% CI
201 azard ratio [HR] 0.39, 80% CI 0.27-0.55; one-sided p=0.0003) and in the erlotinib plus cabozantinib g
206 ebo group (hazard ratio for death, 0.78; one-sided P=0.009), as was event-free survival (hazard ratio
211 sk of death (HR 0.64 [95% CI 0.40-1.05], one-sided p=0.037, whereas the boundary for statistical sign
218 septal deviation (right sided: p=0.962; left-sided: p=0.731), nor unilateral/dominant concha bullosa
221 urogenital examination revealed a small left-sided palpable mass of the testis, compatible with an in
223 milarly, patients transfused through a right-sided PICC were more likely to develop deep-vein thrombo
227 een, we demonstrate that Cas13b has a double-sided protospacer-flanking sequence and elucidate RNA se
229 uperolateral MIL design, connecting the left-sided pulmonary veins with the mitral annulus along the
230 aseline reward-related activity in the right-sided putamen (0.20 [0.93]; F35,3 = 5.64; P = .003).
231 ided PV isolation, and circumferential right-sided PV isolation was performed in the other 3 patients
232 , via posterior gap along the previous right-sided PV isolation, and circumferential right-sided PV i
233 sta terminalis, tricuspid annulus, and right-sided PV via a posterior conduction of previous PV isola
234 tein cages in three shapes-tetrahedron, four-sided pyramid, and triangular prism-with the largest con
235 ents with LBBB, 212 (40%) with complete left-sided reverse remodeling (above-median change in both LA
238 CRT-D patients with LBBB and complete left-sided reverse remodeling had a significantly lower risk
239 e rate and predictive value of complete left-sided reverse remodeling on heart failure (HF) and death
244 d here was protocol-specified and used a two-sided significance level of 0.001 and a p value at or be
247 nea, are common in ARVC/D; yet, classic left-sided signs are typically absent and less than half have
248 lower; if noninferiority was established, 2-sided statistical testing for superiority was conducted.
250 ssion-free survival using a prespecified one-sided stratified log rank test at a significance level o
251 d care) was 1.227 (97.5% CI 0.656-2.292; one-sided stratified log-rank p=0.77); at 24 months, the est
252 ed mid-Proterozoic continental crust via two-sided subduction can account for both the prevalence of
260 The use of zwitterionic hydrogel (a double-sided tape) and commercial superglue is combined and a d
263 with equivalence (g=0.25), using the two one-sided test procedure, and ensuring the efficacy of the c
267 rt of a 19-year-old man presenting with left-sided, total ophthalmoplegia after a traffic accident.
268 RYSTAL and FIRE-3 trials, patients with left-sided tumors (n = 142 and n = 157, respectively) had mar
269 RYSTAL and FIRE-3 trials, patients with left-sided tumors (n = 142 and n = 157, respectively) had mar
272 uximab clearly benefitted patients with left-sided tumors (vs FOLFIRI or FOLFIRI plus bevacizumab, re
274 , respectively), whereas patients with right-sided tumors derived limited benefit from standard treat
275 ns of CRYSTAL and FIRE-3, patients with left-sided tumors had a markedly better prognosis than those
276 ns of CRYSTAL and FIRE-3, patients with left-sided tumors had a markedly better prognosis than those
278 L and FIRE-3 study patients with RAS wt left-sided tumors, FOLFIRI plus cetuximab significantly impro
279 in RAS wt patients with poor-prognosis right-sided tumors, limited efficacy benefits were observed up
283 f 6445; p=0.0010), more frequently had right-sided tumour location (44 [68.8%] of 64 vs 2463 [39.8%]
284 e on patients with severe TR undergoing left-sided valve surgery (class I) or those with mild to mode
285 tricuspid regurgitation at the time of left-sided valve surgery has decreased over time with recogni
288 ated tricuspid annulus at the time of a left-sided valve surgical intervention, even if regurgitation
298 patients with fCCM were more frequently left sided, with 17 of 19 patients having more SFCs in the le
300 n simultaneously map Vm and strain in a left-sided working heart preparation and can image changes in
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。